Significant changes ahead for drug development in China?
Significant changes are ahead for clinical research in China. The Public Consultation Notice for Policies to Encourage Innovation and Reform in Regulation of Drug and Medical Device Clinical Testing was released by the CFDA on 11 May, 2017. These proposed changes herald an exciting new era for drug and device development. If implemented in full, […]
George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division
Sydney, Australia (May 2, 2017) – George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s CRO Division. Effective immediately, the transaction has the dual purpose of strengthening the ability of George Clinical […]
Hong Kong Wholesale Dealer Licence
George Clinical is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significant step forward in George Clinical’s operations in Hong Kong, allowing them to apply for a Certificate of Clinical Trial on behalf of the sponsor and […]
Taiwan: The Clinical Trials Gateway to China?
Taiwan sits, along with its smaller counterparts, Singapore and Hong Kong, as one of the gateway countries to running a clinical trial in China. Although Hong Kong’s regulatory ties are more formalized with China, than Taiwan, Taiwan has the right environment and population to make the possibility of greater regulatory cohesion with its giant neighbour, […]
South Korea: A Top Clinical Trial Destination
Clinical trial sponsors and CROs don’t need to imagine South Korea as a country of limitless potential, they know it is. South Korea is a clinical trial destination with world-class medical infrastructure, a highly-educated, relatively wealthy and healthy population. Their investigators are, on the whole, actively engaged in clinical trials and keen to play their […]
International Women’s Day
As the world stops to celebrate and reflect on International Women’s Day on the 8th of March, George Clinical is proud to play their part in #beboldforchange. Traditionally the commercial research sector has a larger proportion of female practitioners than men. Indeed, at George Clinical, the proportion female to men at 158:73 and with a […]
The George Institute – Winners of the Google Impact Challenge
Video Transcript Congratulations on The Google Impact Challenge win. Can you explain what TEXTCARE does and what issue it addresses? 0:07 – 3:09 It is really exciting; I think we’re all a little bit stunned still, although I feel that we did have a fabulous proposal and it’s very exciting to think that we will […]
Wearables are Improving Clinical Trial Research
The face of individual health care is changing and improving, thanks to wearables. Wearable health and fitness devices are becoming more popular by the day and with our mobile devices and wearables prompting us to keep up with good health habits, overall health is improving too. As individuals are more aware of their health, more […]
Wearables set to impact all areas of healthcare including clinical trials
With the New Year comes new innovations in technology. Many new technological innovations were just announced and launched at the Consumer Electronics Show (CES) in Las Vegas earlier this month. Normally this is not big news for the healthcare industry, or in the area of clinical trials, but this year was an exception. Some very […]
Which clinical trials need a Clinical Endpoint Adjudication Committee?
Increasingly, regulatory authorities are placing significant focus on clinical trial processes that ensure consistent, standardized, objective and unbiased reporting of safety and efficacy results; given that the definitions for many endpoint events include subjective components, and investigator-to-investigator subjective assessments may differ. Moreover, an increasing number of trials are now conducted in multiple geographies, and clinical […]
Case Studies
George Clinical leads China Component and Recruitment in World-First Large CPAP Device Trial
George Clinical Scientific Leaders boost recruitment for Phase 1 Patient Study
Scientific Leadership: Our Communication Framework
Renal Health: Recruitment Success in the Asia-Pacific
Oncology: Recruitment Success in China
